Phosphoproteomic Profiling of In Vivo Signaling in Liver by the Mammalian Target of Rapamycin Complex 1 (mTORC1)
2011

Phosphoproteomic Profiling of mTORC1 Signaling in Rat Liver

Sample size: 6 publication 10 minutes Evidence: high

Author Information

Author(s): Demirkan Gokhan, Yu Kebing, Boylan Joan M., Salomon Arthur R., Gruppuso Philip A.

Primary Institution: Brown University

Hypothesis

The study aims to identify and characterize the phosphorylation events regulated by the mTORC1 signaling pathway in rat liver.

Conclusion

The study successfully identified numerous new phosphorylation sites regulated by mTORC1, demonstrating the feasibility of large-scale phosphoproteomic profiling in vivo.

Supporting Evidence

  • The study identified over 4,000 phosphopeptides, including 62 new rapamycin-responsive phosphorylation sites.
  • Gene ontology analysis showed significant representation of mTOR pathway components among identified phosphopeptides.
  • Phosphorylation of known mTORC1 targets was confirmed to be sensitive to rapamycin treatment.

Takeaway

Researchers looked at how a specific protein complex in rats helps control cell growth and found many new ways it works, which could help us understand diseases better.

Methodology

The study used a phosphoproteomic strategy involving mass spectrometry to analyze liver samples from rats treated with rapamycin after fasting.

Potential Biases

Potential biases may arise from the selection of specific phosphorylation sites and the use of a single animal model.

Limitations

The study may not cover all phosphorylation sites due to the limitations of tryptic digestion and the complexity of the samples.

Participant Demographics

Adult male Sprague-Dawley rats were used in the study.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pone.0021729

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication